Login
$MIRM
$91.58 -$2.41 (2.56%) Live

Company Executives

Officer Age In this role 2025 pay Source
Christopher Peetz Also a director
Chief Executive Officer and Director
47 Not stated $10,441,224
Eric Bjerkholt
Chief Financial Officer
66 Since 2023
3 years
$3,246,216
Peter Radovich
President and Chief Operating Officer
48 Not stated $3,964,270
Rob Myers
Chief Medical Officer
Title from the Form 4 dated Oct 9, 2026
Not stated Not stated Not reported
Jolanda Howe
SVP, GLOBAL CONTROLLER
Title from the Form 4 dated Oct 16, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
8 of 8
stated in the proxy; 1 not stated
Average tenure
5.7 years
from year joined
CEO also chairs the board
No
Michael Grey
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Grey
73 2020
6 years
Independent None stated OnKure Therapeutics, Inc., Spruce Biosciences, Inc. $459,843
Christopher Peetz
47 2019
7 years
Not stated None stated None stated Paid as CEO
Lon Cardon
60 2022
4 years
Independent None stated None stated Not stated
William Fairey
62 2021
5 years
Independent
Audit
Ascendis Pharma, Inc. $421,718
Timothy Walbert
59 2023
3 years
Independent None stated Century Therapeutics, Inc., BioMarin Pharmaceutical Inc., Sagimet Biosciences Inc. $414,843
Laurent Fischer
62 2019
7 years
Independent None stated AtaiBeckley Inc. $429,843
Patrick Heron
55 2018
8 years
Independent
Compensation
Arcutis Biotherapeutics, Inc., MBX Biosciences, Inc. $409,843
Saira Ramasastry
50 2022
4 years
Independent
Audit
Vir Biotechnology, Inc., Glenmark Pharmaceuticals, Ltd., Day One Biopharmaceuticals, Inc. Not stated
Laura Brege
68 2019
7 years
Independent None stated Acadia Pharmaceuticals Inc., Pacira BioSciences, Inc., Edgewise Therapeutics Inc. $440,468

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support